Dai et al. have shown that lncRNA-TUG1 silencing inhibits ovarian cancer development both in vivo and in vitro via the TUG1/miR-582-3p axis (Dai et al., 2021[23]). This evidence concerns the gene TUG1 and ovarian carcinoma.